Traditional Chinese Medicine Monomers for Psoriasis: Mechanistic Insights, Evidence, and Translational Perspectives
Dermatologic Therapy · 2026-01 · 2026 (1)
DOI: 10.1155/dth/3731758 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dermatologic Therapy, online erschienen am 23.07.2026. Verfasst von Wenfei Luo und 1 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Psoriasis is a chronic inflammatory skin disease characterized by immune dysregulation and abnormal keratinocyte proliferation. Traditional Chinese medicine (TCM) monomers, including quercetin, rutin, paeonol, resveratrol, oxymatrine, and ginsenosides, have attracted increasing attention as potential therapeutic candidates. This review summarizes their antipsoriatic effects and molecular mechanisms, focusing on anti‐inflammatory, antioxidant, immunomodulatory, and antiproliferative activities involving key pathways such as IL‐23/IL‐17, NF‐κB, JAK/STAT3, PI3K/AKT, and Nrf2 signaling. Although preclinical studies have shown promising effects in alleviating psoriasis‐like inflammation and modulating pathogenic pathways, clinical evidence remains limited. This review further discusses the translational potential of TCM monomers from the perspectives of advanced topical and transdermal delivery systems, combination therapy, biomarker‐guided treatment, and quality‐controlled clinical development. Future studies should prioritize standardized formulations, pharmacokinetic optimization, long‐term safety evaluation, and well‐designed randomized controlled trials to determine their potential value as adjunctive therapeutic candidates for psoriasis.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Luo, W., & Shi, H. (2026). Traditional Chinese Medicine Monomers for Psoriasis: Mechanistic Insights, Evidence, and Translational Perspectives. Dermatologic Therapy, 2026(1). https://doi.org/10.1155/dth/3731758
Vancouver
Luo W, Shi H. Traditional Chinese Medicine Monomers for Psoriasis: Mechanistic Insights, Evidence, and Translational Perspectives. Dermatologic Therapy. 2026;2026(1). doi:10.1155/dth/3731758
BibTeX
@article{Luo2026,
author = {Luo, Wenfei and Shi, Huijuan},
title = {Traditional Chinese Medicine Monomers for Psoriasis: Mechanistic Insights, Evidence, and Translational Perspectives},
journal = {Dermatologic Therapy},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/dth/3731758}
}
EUVIMED